Table of Contents
1. Executive Summary
2. Market Overview
3. Market Background
4. North America Industry Analysis 2019 to 2023 and Forecast, 2024 to 2034
5. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Class
- 5.1. Amphetamines
- 5.2. Alcohol
- 5.3. Barbiturates
- 5.4. Benzodiazepines
- 5.5. Illicit Drugs
- 5.6. Opiates/Opioids
- 5.7. Tricyclic’s Antidepressants
- 5.8. Z Drugs
6. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
- 6.1. Reagent and Kits
- 6.1.1. ELISA
- 6.1.2. PCR
- 6.1.3. Enzyme Multiplied Immunoassay Technique (EMIT)
- 6.1.4. Radio Immuno-sorbent Assay (RIA)
- 6.2. Instruments
- 6.2.1. Immunochemistry Analyzers
- 6.2.2. PCR Machine
- 6.2.3. Gas Chromatography/Mass Spectrometry (GS/MS)
- 6.2.4. High Performance Liquid Chromatography (HPLC)
7. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sample
- 7.1. Urine
- 7.2. Blood
- 7.3. Hair
- 7.4. Oral Fluid
8. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User
- 8.1. Hospitals
- 8.2. Clinics
- 8.3. Diagnostic Laboratories
- 8.4. Forensic Laboratories
- 8.5. Rehabilitation Centres
9. North America Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
- 9.1. U.S.
- 9.2. Canada
10. U.S. Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
11. Canada Industry Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
12. Market Structure Analysis
13. Competition Analysis
- 13.1. Thermo Fisher Scientific, Inc
- 13.2. Danaher Corporation
- 13.3. Agilent Technologies
- 13.4. Alere, Inc.
- 13.5. Bio Rad Laboratories Inc.
- 13.6. Neogen Corporation
- 13.7. Redwood Toxicology Laboratory
- 13.8. Principle Laboratory
- 13.9. Pacific Toxicology Laboratories
- 13.10. Medical Toxicology Laboratory, LLC
14. Assumptions & Acronyms Used
15. Research Methodology
List of Tables
Table 01: North America Industry Value (US$ Million) Forecast by Region, 2019 to 2034
Table 02: North America Industry Volume (Units) Forecast by Region, 2019 to 2034
Table 03: North America Industry Value (US$ Million) Forecast by Drug Class, 2019 to 2034
Table 04: North America Industry Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 05: North America Industry Value (US$ Million) Forecast by Product, 2019 to 2034
Table 06: North America Industry Volume (Units) Forecast by Product, 2019 to 2034
Table 07: North America Industry Value (US$ Million) Forecast by Sample, 2019 to 2034
Table 08: North America Industry Volume (Units) Forecast by Sample, 2019 to 2034
Table 09: North America Industry Value (US$ Million) Forecast by End User, 2019 to 2034
Table 10: North America Industry Volume (Units) Forecast by End User, 2019 to 2034
Table 11: U.S. Industry Value (US$ Million) Forecast by Region, 2019 to 2034
Table 12: U.S. Industry Volume (Units) Forecast by Region, 2019 to 2034
Table 13: U.S. Industry Value (US$ Million) Forecast by Drug Class, 2019 to 2034
Table 14: U.S. Industry Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 15: U.S. Industry Value (US$ Million) Forecast by Product, 2019 to 2034
Table 16: U.S. Industry Volume (Units) Forecast by Product, 2019 to 2034
Table 17: U.S. Industry Value (US$ Million) Forecast by Sample, 2019 to 2034
Table 18: U.S. Industry Volume (Units) Forecast by Sample, 2019 to 2034
Table 19: U.S. Industry Value (US$ Million) Forecast by End User, 2019 to 2034
Table 20: U.S. Industry Volume (Units) Forecast by End User, 2019 to 2034
Table 21: Canada Industry Value (US$ Million) Forecast by Region, 2019 to 2034
Table 22: Canada Industry Volume (Units) Forecast by Region, 2019 to 2034
Table 23: Canada Industry Value (US$ Million) Forecast by Drug Class, 2019 to 2034
Table 24: Canada Industry Volume (Units) Forecast by Drug Class, 2019 to 2034
Table 25: Canada Industry Value (US$ Million) Forecast by Product, 2019 to 2034
Table 26: Canada Industry Volume (Units) Forecast by Product, 2019 to 2034
Table 27: Canada Industry Value (US$ Million) Forecast by Sample, 2019 to 2034
Table 28: Canada Industry Volume (Units) Forecast by Sample, 2019 to 2034
Table 29: Canada Industry Value (US$ Million) Forecast by End User, 2019 to 2034
Table 30: Canada Industry Volume (Units) Forecast by End User, 2019 to 2034
List of Figures
Figure 01: North America Industry Value (US$ Million) by Drug Class, 2024 to 2034
Figure 02: North America Industry Value (US$ Million) by Product, 2024 to 2034
Figure 03: North America Industry Value (US$ Million) by Sample, 2024 to 2034
Figure 04: North America Industry Value (US$ Million) by End User, 2024 to 2034
Figure 05: North America Industry Value (US$ Million) by Country, 2024 to 2034
Figure 06: North America Industry Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 07: North America Industry Volume (Units) Analysis by Country, 2019 to 2034
Figure 08: North America Industry Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 09: North America Industry Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 10: North America Industry Value (US$ Million) Analysis by Drug Class, 2019 to 2034
Figure 11: North America Industry Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 12: North America Industry Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 13: North America Industry Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 14: North America Industry Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 15: North America Industry Volume (Units) Analysis by Product, 2019 to 2034
Figure 16: North America Industry Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 17: North America Industry Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 18: North America Industry Value (US$ Million) Analysis by Sample, 2019 to 2034
Figure 19: North America Industry Volume (Units) Analysis by Sample, 2019 to 2034
Figure 20: North America Industry Value Share (%) and BPS Analysis by Sample, 2024 to 2034
Figure 21: North America Industry Y-o-Y Growth (%) Projections by Sample, 2024 to 2034
Figure 22: North America Industry Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 23: North America Industry Volume (Units) Analysis by End User, 2019 to 2034
Figure 24: North America Industry Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 25: North America Industry Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 26: North America Industry Attractiveness by Drug Class, 2024 to 2034
Figure 27: North America Industry Attractiveness by Product, 2024 to 2034
Figure 28: North America Industry Attractiveness by Sample, 2024 to 2034
Figure 29: North America Industry Attractiveness by End User, 2024 to 2034
Figure 30: North America Industry Attractiveness by Country, 2024 to 2034
Figure 31: U.S. Industry Value (US$ Million) by Drug Class, 2024 to 2034
Figure 32: U.S. Industry Value (US$ Million) by Product, 2024 to 2034
Figure 33: U.S. Industry Value (US$ Million) by Sample, 2024 to 2034
Figure 34: U.S. Industry Value (US$ Million) by End User, 2024 to 2034
Figure 35: U.S. Industry Value (US$ Million) by Region, 2024 to 2034
Figure 36: U.S. Industry Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 37: U.S. Industry Volume (Units) Analysis by Region, 2019 to 2034
Figure 38: U.S. Industry Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 39: U.S. Industry Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 40: U.S. Industry Value (US$ Million) Analysis by Drug Class, 2019 to 2034
Figure 41: U.S. Industry Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 42: U.S. Industry Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 43: U.S. Industry Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 44: U.S. Industry Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 45: U.S. Industry Volume (Units) Analysis by Product, 2019 to 2034
Figure 46: U.S. Industry Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 47: U.S. Industry Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 48: U.S. Industry Value (US$ Million) Analysis by Sample, 2019 to 2034
Figure 49: U.S. Industry Volume (Units) Analysis by Sample, 2019 to 2034
Figure 50: U.S. Industry Value Share (%) and BPS Analysis by Sample, 2024 to 2034
Figure 51: U.S. Industry Y-o-Y Growth (%) Projections by Sample, 2024 to 2034
Figure 52: U.S. Industry Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 53: U.S. Industry Volume (Units) Analysis by End User, 2019 to 2034
Figure 54: U.S. Industry Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 55: U.S. Industry Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 56: U.S. Industry Attractiveness by Drug Class, 2024 to 2034
Figure 57: U.S. Industry Attractiveness by Product, 2024 to 2034
Figure 58: U.S. Industry Attractiveness by Sample, 2024 to 2034
Figure 59: U.S. Industry Attractiveness by End User, 2024 to 2034
Figure 60: U.S. Industry Attractiveness by Region, 2024 to 2034
Figure 61: Canada Industry Value (US$ Million) by Drug Class, 2024 to 2034
Figure 62: Canada Industry Value (US$ Million) by Product, 2024 to 2034
Figure 63: Canada Industry Value (US$ Million) by Sample, 2024 to 2034
Figure 64: Canada Industry Value (US$ Million) by End User, 2024 to 2034
Figure 65: Canada Industry Value (US$ Million) by Region, 2024 to 2034
Figure 66: Canada Industry Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 67: Canada Industry Volume (Units) Analysis by Region, 2019 to 2034
Figure 68: Canada Industry Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 69: Canada Industry Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 70: Canada Industry Value (US$ Million) Analysis by Drug Class, 2019 to 2034
Figure 71: Canada Industry Volume (Units) Analysis by Drug Class, 2019 to 2034
Figure 72: Canada Industry Value Share (%) and BPS Analysis by Drug Class, 2024 to 2034
Figure 73: Canada Industry Y-o-Y Growth (%) Projections by Drug Class, 2024 to 2034
Figure 74: Canada Industry Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 75: Canada Industry Volume (Units) Analysis by Product, 2019 to 2034
Figure 76: Canada Industry Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 77: Canada Industry Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 78: Canada Industry Value (US$ Million) Analysis by Sample, 2019 to 2034
Figure 79: Canada Industry Volume (Units) Analysis by Sample, 2019 to 2034
Figure 80: Canada Industry Value Share (%) and BPS Analysis by Sample, 2024 to 2034
Figure 81: Canada Industry Y-o-Y Growth (%) Projections by Sample, 2024 to 2034
Figure 82: Canada Industry Value (US$ Million) Analysis by End User, 2019 to 2034
Figure 83: Canada Industry Volume (Units) Analysis by End User, 2019 to 2034
Figure 84: Canada Industry Value Share (%) and BPS Analysis by End User, 2024 to 2034
Figure 85: Canada Industry Y-o-Y Growth (%) Projections by End User, 2024 to 2034
Figure 86: Canada Industry Attractiveness by Drug Class, 2024 to 2034
Figure 87: Canada Industry Attractiveness by Product, 2024 to 2034
Figure 88: Canada Industry Attractiveness by Sample, 2024 to 2034
Figure 89: Canada Industry Attractiveness by End User, 2024 to 2034
Figure 90: Canada Industry Attractiveness by Region, 2024 to 2034
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF